| 5 | 2/1 | 返回列表 |
| 查看: 5953 | 回復(fù): 30 | |||
| 當(dāng)前只顯示滿(mǎn)足指定條件的回帖,點(diǎn)擊這里查看本話(huà)題的所有回帖 | |||
F_Shaw捐助貴賓 (著名寫(xiě)手)
|
[交流]
兩個(gè)審稿人給出了大改,但Associate Editor給了拒稿 已有3人參與
|
||
|
Dear Dr. XXXX, Reviewers' comments on your work have now been received. You will see that they are advising that we consider accepting your paper after major revision. However the needed revisions are too substantion to allow the paper to proceed without a second round of review. Please consider my rejection this version a "soft" decision. Both reviewers have indicated that they would like to see the revision and they will be invited to review the new submission. Both reviewers have agreed to be identified. XXXX is Reviewer #1, and XXXXX is Reivewer #2. Both reviewers have downloaded files in addition to the comments listed below. Let me know if you have any problems downloading this files. The one issue that must be addressed in a revision is a clear distinguition from previous publihsed papers. It is fine to document how new data supports conclusions made in prior work, but these must be significant advances and you must be clear as to why the new information either proves or disproves previous studies. Considering the extent of revision needed, I have not provided any editorial input to this version. I would be willing to help you with the revision prior to your formal resubmission. The easiest way to do this is for you to email me your revised manuscript (XXXXXXX) and we can work outside of the Elsevier system. ———————————————— Reviewer #1: The purpose of this paper, as poorly stated in lines 90-95,XXXXXX. I completely re-wrote this paper because without doing so, it would have been impossible to understand the aim of the work. Although the paper is very poorly written, it may be worthy of publication with major revisions. I have two major objections (items 1-2 below) and several recommendations for the authors. XXXXXXX ———————————————— Reviewer #2: The manuscript presented a valuable case study on XXXXX. XXXXXXXXXX. The data analysis is logical, the conclusions are convincing in general. The figures and tables are largely adequate to support the points made in the current manusript. The length of the manuscript is about right, although it could be slightly longer if the authors are going to make revisions according to the reviewer's suggestions. Major issues with the current manuscript include the following: XXXXXXXXX ______________________ 兩個(gè)審稿人提了很多意見(jiàn),Associate Editor的意思是在我重投之前,可以協(xié)助我修改,工作量有點(diǎn)大! 各位蟲(chóng)友有沒(méi)有這樣的經(jīng)歷,像這樣機(jī)會(huì)大不大? [ Last edited by F_Shaw on 2014-4-11 at 13:58 ] |

木蟲(chóng) (正式寫(xiě)手)

![]() ![]() ![]() |
鐵桿木蟲(chóng) (知名作家)

| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 283求調(diào)劑(080500) +14 | A child 2026-03-27 | 14/700 |
|
|---|---|---|---|---|
|
[碩博家園] 求調(diào)劑 有機(jī)化學(xué)考研356分 +10 | Nadiums 2026-03-25 | 11/550 |
|
|
[考研] 292求調(diào)劑 +8 | 是妍子也是研子 2026-03-30 | 8/400 |
|
|
[考研] 求調(diào)劑,一志愿 南京航空航天大學(xué)大學(xué) ,080500材料科學(xué)與工程學(xué)碩 +6 | @taotao 2026-03-26 | 7/350 |
|
|
[考研] 311求調(diào)劑 +10 | lin0039 2026-03-26 | 10/500 |
|
|
[考研] 0703 化學(xué) 求調(diào)劑,一志愿山東大學(xué) 342 分 +6 | Shern—- 2026-03-28 | 6/300 |
|
|
[考研] 295求調(diào)劑 +5 | wei-5 2026-03-26 | 5/250 |
|
|
[考研] 085600 286分 材料求調(diào)劑 +10 | 麻辣魷魚(yú) 2026-03-27 | 11/550 |
|
|
[考研] 學(xué)碩274求調(diào)劑 +9 | Li李魚(yú) 2026-03-26 | 9/450 |
|
|
[考研] 312,生物學(xué)求調(diào)劑 +3 | 小譯同學(xué)abc 2026-03-28 | 3/150 |
|
|
[考研] 339求調(diào)劑,想調(diào)回江蘇 +6 | 烤麥芽 2026-03-27 | 8/400 |
|
|
[考研] 266求調(diào)劑 +11 | 陽(yáng)陽(yáng)哇塞 2026-03-27 | 12/600 |
|
|
[考研] 一志愿南師大0703化學(xué) 275求調(diào)劑 +4 | Ripcord上岸 2026-03-27 | 4/200 |
|
|
[考研] 0703化學(xué)338求調(diào)劑! +6 | Zuhui0306 2026-03-26 | 7/350 |
|
|
[考研] 324求調(diào)劑 +5 | hanamiko 2026-03-26 | 5/250 |
|
|
[考研] 286求調(diào)劑 +4 | lim0922 2026-03-26 | 4/200 |
|
|
[考研] 一志愿陜師大生物學(xué)071000,298分,求調(diào)劑 +5 | SYA! 2026-03-23 | 5/250 |
|
|
[考研] 0703化學(xué)求調(diào)劑 +3 | 丹青奶蓋 2026-03-26 | 5/250 |
|
|
[考研] 求調(diào)劑 +3 | 李李不服輸 2026-03-25 | 3/150 |
|
|
[考研] 調(diào)劑 +4 | 13853210211 2026-03-24 | 4/200 |
|